Skip to the latest updates
Clintelo — Innovation IQ for PhysiciansClintelo
My Clintelo

Neurology. What changed.

New drugs and devices in neurology, newest first, each with its bottom line.

As of , Clintelo tracks 2 innovations in neurology: 1 drug (Juvmo (tavapadon)) and 1 device (neuropacs). Each is written from the FDA's announcement or the developer's own release.

Drug IQ in Neurology

Search 1 in Drug IQ
  1. Drug IQFDA approvalJuvmo (tavapadon)Parkinson's disease · AbbVieAdults with Parkinson's disease have a once-daily oral dopamine agonist that can be used with or without levodopa. In Phase 3 trials it improved activities of daily living scores in early disease and, added to levodopa, increased "on" time without troublesome dyskinesia.

Device IQ in Neurology

Search 1 in Device IQ
  1. Device IQGranted · De NovoneuropacsDifferentiating MSAp and PSP from Parkinson's disease · NeuropacsNeuroradiologists and neurologists can get a supplemental report from one diffusion MRI scan, without a radiotracer, to help differentiate MSAp and PSP from Parkinson's disease. It is not a standalone diagnostic, and patient management decisions should not be based solely on its output.